Construction of adeno-associated virus coexpression system for human angiopoietin-1 and VEGF gene

Chinese Medical Journal

Volumn 117, Issue 4, 2004, Pages 562-565

  Chen, De Jie ^a   Tan, Zui ^a   Xie, You Li ^a   Liu, Fang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adeno associated virus; Angiopoietin 1; Plasmids; VEGF (165)

Indexed keywords

ANGIOPOIETIN 1; PARVOVIRUS VECTOR; PLASMID VECTOR; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE CONSTRUCT; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE IDENTIFICATION; HUMAN; ISCHEMIC HEART DISEASE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANGIOPOIETIN-1; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; PLASMIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2342642758     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Risau W. Mechanisms of angiogenesis. Nature 1997;386: 671-674.
2. Sundberg C, Kowanetz M, Brown LF, et al. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 2002;82:387-401.
3. Clauss M. Functions of the VEGF receptor-1 (FLT-1) in the vasculature. Trends Cardiovasc Med 1998;8:241-245.
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
5. Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 1999;96:1904-1909.
6. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
7. Koblizek TI, Weiss C, Yancopoulos GD, et al. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998;8: 529-532.
8. Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998;273:18514-18521.
9. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
10. Asahara T, Chen D, Takahashi T, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-reduced postnatal neovascularization. Circ Res 1998;83:233-240.
11. Zhang Z, Dong H, Liu J, et al. Vascular endothelial growth factor gene transfer improves host endothelialization of xenogeneic biologic heart valve in vivo. Chin Med J 2002; 115:878-883.
12. Baumgartner I, Pieczek AR, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-1123.
13. Bueler H. Adeno-associated viral vectors for gene transfer and gene therapy. Biol Chem 1999;380:613-622.
14. Zaiss AK, Liu Q, Bowen GP, et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002;76:4580-4590.
15. Smith-Arica JR, Bartlett JS. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep 2001;3:43-49.
16. Zhou H, Zeng G, Zhu X, et al. Enhanced adeno-associated virus vector expression by adenovirus protein-cationic liposome complex. A novel and high efficient way to introduce foreign DNA into endothelial cells. Chin Med J 1995;108: 332-337.